摘要
目的:探讨缬沙坦联合硝苯地平缓释片治疗老年性高血压的临床效果。方法:选择确诊为原发性高血压门诊及住院老年患者170例,52例患者采用缬沙坦治疗,分为A组;56例患者采用硝苯地平缓释片治疗,分为B组;62例患者采用缬沙坦联合硝苯地平缓释片治疗,分为C组。治疗6周后,比较各组临床效果及治疗前后收缩压(SBP)和舒张压(DBP)变化的差值。结果:联合用药治疗效果及控制血压效果好于单一用药效果。结论:缬沙坦联合硝苯地平缓释片治疗老年性高血压安全有效,临床效果好于单一用药效果。
Objective： To discuss the clinical effect of Valsartan combined with Nifedipine sustained-release in treatment of senile hypertension. Method： Collect 170 elder patients with Essential hypertension,52 patients were divided into A group with Valsartan treatment; 56 patients were divided into B group with Nifedipine sustained-release treatment;62 patients were divided into C group with two drugs treatment, then compare clinical effect, SBP and DBP changes after 6 weeks. Result： Combination group was better than single agent group in clinical effect and control of blood pressure effect. Conclusion： Valsartan combined with Nifedipine sustained-release was safe and effective in treatment of senile hypertension and better than single agent in clinical effect.
出处
《现代生物医学进展》
CAS
2010年第20期3908-3910,共3页
Progress in Modern Biomedicine
关键词
缬沙坦
硝苯地平缓释片
老年性
原发性高血压
Valsartan； Nifedipine sustained-release； Senile； Essential hypertension；
